0001104659-16-108205.txt : 20160329 0001104659-16-108205.hdr.sgml : 20160329 20160329115423 ACCESSION NUMBER: 0001104659-16-108205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160329 FILED AS OF DATE: 20160329 DATE AS OF CHANGE: 20160329 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADAMS STREET PARTNERS LLC CENTRAL INDEX KEY: 0001193586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 161534331 MAIL ADDRESS: STREET 1: ONE NORTH WACKER DRIVE STREET 2: STE 2200 CITY: CHICAGO STATE: IL ZIP: 60606-2807 4 1 a4.xml 4 X0306 4 2016-03-29 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001193586 ADAMS STREET PARTNERS LLC ONE NORTH WACKER, SUITE 2200 CHICAGO IL 60606 0 0 1 0 Common Stock, $0.0001 par value 2016-03-29 4 C 0 550864 A 550864 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 92278 A 643142 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 P 0 51712 15.00 A 694854 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 567121 A 567121 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 95001 A 662122 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 P 0 53239 15.00 A 715361 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 428998 A 428998 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 71863 A 500861 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 P 0 40272 15.00 A 541133 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 583510 A 583510 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 C 0 97746 A 681256 I By Fund Common Stock, $0.0001 par value 2016-03-29 4 P 0 54777 15.00 A 736033 I By Fund Series A Convertible Preferred Stock 2016-03-29 4 C 0 550864 D Common Stock 550864 0 I By Fund Series B Convertible Preferred Stock 2016-03-29 4 C 0 92278 D Common Stock 92278 0 I By Fund Series A Convertible Preferred Stock 2016-03-29 4 C 0 567121 D Common Stock 567121 0 I By Fund Series B Convertible Preferred Stock 2016-03-29 4 C 0 95001 D Common Stock 95001 0 I By Fund Series A Convertible Preferred Stock 2016-03-29 4 C 0 428998 D Common Stock 428998 0 I By Fund Series B Convertible Preferred Stock 2016-03-29 4 C 0 71863 D Common Stock 71863 0 I By Fund Series A Convertible Preferred Stock 2016-03-29 4 C 0 583510 D Common Stock 583510 0 I By Fund Series B Convertible Preferred Stock 2016-03-29 4 C 0 97746 D Common Stock 97746 0 I By Fund The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis at the consummation of Issuer's initial public offering. Represents shares held directly by Adams Street 2011 Direct Fund LP ("AS 2011"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2011, may be deemed to beneficially own the shares held by AS 2011. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2011. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2011 except to the extent of their pecuniary interest therein. Represents shares held directly by Adams Street 2012 Direct Fund LP ("AS 2012"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2012, may be deemed to beneficially own the shares held by AS 2012. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2012. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2012 except to the extent of their pecuniary interest therein. Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein. Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein. The expiration date is not relevant to the conversion of these securities. AS 2011, AS 2012, AS 2013 and AS 2014 purchased an aggregate of 200,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share. /s/ Sara Robinson Dasse 2016-03-29